Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Moleculin Biotech Inc (NASDAQ: MBRX) closed the day trading at $0.49 up 0.58% from the previous closing price of $0.48. In other words, the price has increased by $0.58 from its previous closing price. On the day, 1.75 million shares were traded. MBRX stock price reached its highest trading level at $0.4999 during the session, while it also had its lowest trading level at $0.4732.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 23 ’25 when Foster Jonathan P. bought 270,270 shares for $0.37 per share. The transaction valued at 100,000 led to the insider holds 287,587 shares of the business.
KLEMP WALTER V bought 675,675 shares of MBRX for $250,000 on Jun 23 ’25. The CEO and President now owns 743,607 shares after completing the transaction at $0.37 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBRX now has a Market Capitalization of 24006810 and an Enterprise Value of 7551791.
Stock Price History:
The Beta on a monthly basis for MBRX is 1.58, which has changed by -0.8098039 over the last 52 weeks, in comparison to a change of 0.15927899 over the same period for the S&P500. Over the past 52 weeks, MBRX has reached a high of $3.65, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is -6.29%, while the 200-Day Moving Average is calculated to be -47.38%.
Shares Statistics:
Over the past 3-months, MBRX traded about 5.55M shares per day on average, while over the past 10 days, MBRX traded about 3154380 shares per day. A total of 49.50M shares are outstanding, with a floating share count of 45.11M. Insiders hold about 8.87% of the company’s shares, while institutions hold 0.87% stake in the company. Shares short for MBRX as of 1757894400 were 2347632 with a Short Ratio of 0.42, compared to 1755216000 on 3297491. Therefore, it implies a Short% of Shares Outstanding of 2347632 and a Short% of Float of 6.59.
Earnings Estimates
The stock of Moleculin Biotech Inc (MBRX) is currently drawing attention from 3.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.13 and low estimates of -$0.42.
Analysts are recommending an EPS of between -$5.28 and -$5.28 for the fiscal current year, implying an average EPS of -$5.28. EPS for the following year is -$4.85, with 1.0 analysts recommending between -$4.85 and -$4.85.
